Related Experiment Video
Updated: Jun 3, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Treatment of multiple sclerosis exacerbations
1Multiple Sclerosis Center, Swedish Neuroscience Institute, 1600 East Jefferson Street, Suite 205, Seattle, WA 98122, USA.
Neurologic Clinics
|March 29, 2011
Summary
Novel treatments for relapsing multiple sclerosis (MS) are emerging, yet MS exacerbations remain a concern. This review covers current treatment options for acute MS relapses, focusing on efficacy and safety.
Area of Science:
- Neurology
- Immunology
Background:
- Understanding of multiple sclerosis (MS) exacerbation mechanisms drives new treatments for relapsing forms.
- Despite potent therapies, MS exacerbations remain a significant clinical concern for patients and healthcare providers.
Purpose of the Study:
- To review current treatment options for acute MS exacerbations.
- To discuss the implementation, side effects, and evidence supporting the efficacy of these treatments for MS relapse recovery.
Main Methods:
- Literature review of available treatment options for acute MS exacerbations.
- Analysis of evidence supporting treatment efficacy in promoting recovery from MS relapses.
Main Results:
- Multiple treatment options exist for managing acute MS exacerbations.
- Evidence supports the efficacy of various treatments in facilitating recovery from MS relapses, though exacerbations can still occur.
Conclusions:
- Treatment of acute MS exacerbations is crucial in comprehensive MS care.
- Available therapies aim to promote recovery and manage side effects, but ongoing research is vital.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...